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Introduction
Obstructive hydrocephalus develops due to 
a  blockage in circulation of the cerebrospinal flu-
id (CSF). From the clinical point of view, obstructive 
hydrocephalus results from diseases causing an 
occlusion in the ventricular system, and it is also 
termed non-communicating hydrocephalus [1]. The 
issue of treatment in obstructive hydrocephalus has 
been subject to evolution for years – from the first 
experience of Dandy and Mixter with an endoscop-
ic approach, through shunt placement introduced 
by Nulsen and Spitz, to the increasingly appreciated 
endoscopic third ventriculostomy (ETV) nowadays 
[2]. Endoscopic third ventriculostomy is a  well-es-
tablished method of treatment in pediatric neuro-
surgery, allowing a reduction in the number of shunt 
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A b s t r a c t
Introduction: After a time of domination of shunt placement, endoscopic third ventriculostomy (ETV) has been in-
creasingly applied in treatment of obstructive hydrocephalus.
Aim: To assess the effectiveness of ETV in treatment of adults with three-ventricle hydrocephalus of different etiology.
Material and methods: Ninety-six patients with obstructive hydrocephalus were studied: 24 with primary aque-
ductal stenosis, 61 with brain tumor, and 2 with basilar tip aneurysm. In 9 patients the etiology of hydrocephalus 
remained undetermined. The assessment of treatment results was based on clinical and radiological criteria.
Results: Clinical improvement was observed in 74 (77.1%) patients, and radiological improvement in 52 (54.2%). One 
patient died. Follow-up of 24 patients with primary aqueductal stenosis has shown that in 20 (83.3%) of them clin-
ical improvement has been stable, and in 14 (58.3%) radiological improvement has been observed. Two patients re-
quired shunt placement due to hydrocephalus recurrence 12–24 months after the ETV procedure. Among 9 patients 
with undefined hydrocephalus, 3 required shunt placement within 6 months after ETV (2 shunted previously). Endo-
scopic third ventriculostomy treatment in a patient with hydrocephalus caused by basilar tip aneurysm succeeded. 
The assessment of ETV effectiveness in oncological patients has been indirect in view of the underlying disease.
Conclusions: The best results of ETV treatment have been demonstrated for patients with primary aqueductal ste-
nosis. Ventricle size cannot determine the effectiveness of treatment as an individual requirement. Endoscopic third 
ventriculostomy is effective in previously shunted patients although the prediction of outcome should be cautious. 
Endoscopic third ventriculostomy enables preparation for further therapy and is palliative treatment in oncological 
patients with secondary hydrocephalus.
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placements, while there are fewer reports on this top-
ic in adults [3, 4]. So far there is no effective, simple 
diagnostic method that allows for proper selection of 
patients for ETV. Theoretically, the greatest efficacy 
of ETV should be achieved in cases of non-communi-
cating hydrocephalus with preserved patency of the 
subarachnoid space, up to the point of absorbing the 
CSF [4]. However, in practice, the qualification for ETV 
often is based on empirical grounds.
Aim
The aim of this study is to present short- and 
long-term results of ETV treatment in adults with 
three-ventricle hydrocephalus of different etiology.
Material and methods
Ninety-six patients with obstructive hydroceph-
alus undergoing operations over the past 10 years 
in our Neurosurgery Department were studied. The 
study group consisted of 41 women and 55 men 
aged 18–82 years (average age 47 years). In all pa-
tients the initial diagnosis was made based on head 
computed tomography (CT) or magnetic resonance 
imaging (MRI) scan or both, performed before or at 
the time of admission. A variety of findings present-
ed in neurological examination were associated with 
hydrocephalus alone and in some cases with under-
lying disease causing hydrocephalus (Table I). In case 
of uncertainty about the final diagnosis, head MRI 
T2-weighted images were of critical importance. In 
56 patients active hydrocephalus with periventricu-
lar lucency of the CSF and clamping of the cerebral 
sulci were found. In 3 cases, due to suspicion of vas-
cular malformation (basilar tip aneurysm), diagnos-
tic procedures were expanded by: digital subtraction 
angiography in 2 cases and angio-CT scan in 1 case. 
Etiology of obstructive hydrocephalus in the study 
group is presented in Table II. In 9 cases the cause 
of hydrocephalus remained undetermined with un-
equivocal radiological presentation of hydrocepha-
lus. In 1 patient with primary aqueductal stenosis, 
the MRI scan revealed in the vicinity of the sylvian 
aqueduct a  small hyperintense lesion of unknown 
etiology, observed in further scans. In patients with 
tumor of the posterior portion of the third ventricle, 
in 14 patients with cerebellopontine angle tumor 
and in 10 patients with cerebellar tumor the ETV 
procedure was preparation for the further stages of 
treatment. In 3 patients with cerebellopontine angle 
tumor and in 2 patients with cerebellar tumor (in all 
cases: large tumor size, poor general condition of pa-
tient, advanced age of patient) as well as in patients 
with multiple metastases and in patients with mes-
encephalic tumor ETV was a  palliative procedure. 
Five patients with hydrocephalus of undetermined 
etiology had been previously shunted and were ad-
mitted with symptoms of shunt dysfunction. Stud-
ied patients have not received any particular phar-
macological treatment. In case of coexisting brain 
edema, a standard approach was implemented. 
The aim of ETV is to communicate the third ven-
tricle with the interpeduncular cistern and create 
flow which bypasses an obstruction to the circula-
tion of the CSF. The important step in preoperative 
planning is the assessment of conditions for fenes-
Table I. Clinical symptoms in 96 patients with 
obstructive hydrocephalus
Type of symptoms Number  
of patients
Symptoms of intracranial hypertension 71
Cognitive disorders 51
Gait disturbance 45
Urine incontinence 33
Locomotor ataxia 25
Cranial nerve palsy 18
Hemiparesis 12
Parinaud’s symptom 10
Table II. Etiology of the obstructive hydrocepha-
lus in studied patients
Cause of hydrocephalus Number  
of patients
Primary aqueductal stenosis 24
Tumor of posterior portion of the third 
ventricle
19
Cerebellopontine angle tumor 17
Cerebellar tumor 12
Multiple metastases 8
Mesencephalic tumor 5
Basilar tip aneurysm 2
Undefined 9
Total 96
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tration in the floor of the third ventricle. In all pa-
tients the final selection for the ETV procedure was 
based on neuroimaging analysis with at least axial 
and sagittal sections. In several cases initial diagnos-
tics had to be supplemented to meet these require-
ments. The width of lateral ventricles, the width of 
the third ventricle and the distance between the cli-
vus and basilar artery were analyzed. Their appropri-
ate size allows handling of the endoscope without 
an increased risk to the surrounding structures and 
performing safe ventriculostomy. The optimal trajec-
tory of the endoscopic approach to the floor of the 
third ventricle was obtained by a  burr hole placed 
in the right frontal area 1 cm in front of the coronal 
suture and 2–3 cm from the midline (Kocher’s point). 
In some patients placement of the entry point was 
modified based on planimetric measurements made 
on sagittal scans.
During the ETV procedure the patient was po-
sitioned supine with anteflexed head stabilized in 
a  Mayfield head holder. The rigid Karl Storz GAAB 
model endoscope with Hopkins 0° optics having 
the outer diameter of 6.5 mm and 3 mm working 
channel diameter was the most commonly used. 
The intracranial approach was performed with the 
burr hole diameter of 10 mm. After dura incision 
and arachnoid coagulation, the lateral ventricle was 
punctured using a Cushing needle that was directed 
towards the base of the nose and external acoustic 
foramen. Manometric measurement of CSF pressure 
and estimation of the distance between the brain 
surface and ventricle were made. Using the same 
trajectory the endoscopic sheath was introduced 
with the aid of a  trocar replaced in the next stage 
with the endoscope. Some of the procedures were 
performed free hand and most of them with the use 
of a frame fixing endoscope. After the lateral ventri-
cle was reached, the foramen of Monro and situated 
laterally the head of the caudate nuclei and medially 
the pellucid septum were indentified. A great ana-
tomical landmark was the choroid plexus passing 
through the foramen of Monro to the third ventri-
cle, and visible in its lower margin the point where 
the thalamostriate vein unites with the septal vein. 
Then the endoscope was introduced into the third 
ventricle, keeping a safe distance from the structures 
mentioned above and from columns of fornix limit-
ing the foramen of Monro from the anterior-medial 
side. In the third ventricle (moving the endoscope 
forward) the infundibular recess, mammillary bod-
ies and if possible the dorsum sellae and basilar tip 
were indentified. The infundibular recess and mam-
millary bodies form a triangle, which is an anatom-
ical equivalent of the tuber cinereum – a structure 
that, in the case of hydrocephalus, is usually thin. 
Ventriculostomy was performed in the anterior part 
of the described triangle by perforation of the floor 
of the third ventricle to the interpeduncular cistern. 
The technique of fenestration was dependent on the 
structure of the floor. If the floor was thin, use of 
a  Fogarty balloon catheter no. 3 was sufficient. In 
case of increased vascularization of the floor, bipolar 
coagulation was used first and then a Fogarty cath-
eter or forceps to enlarge the perforation. Occasion-
ally occurring bleeding was brought under control by 
irrigation of the operative field with Ringer’s solution 
at the temperature of 36–37°C. After withdrawal of 
the neuroendoscope, the hole in the dura was closed 
with TachoSil. The galea and the skin were tightly 
sutured (Photos 1 A–E).
To evaluate the treatment results, clinical and ra-
diological criteria were used. Neurological examina-
tion was performed according to the generally appli-
cable protocol. Neuroimaging studies including head 
CT or MRI were performed and evaluated by the same 
team of radiologists. The first follow-up scan was car-
ried out within 48 h after surgery and then 1 month, 
6 months and about a year after the operation. Fur-
ther follow-up scans took place in most patients at 
annual intervals. In case of reasonable suspicion of 
ETV treatment failure or complications, the described 
schedule was modified. The criteria for clinical im-
provement were remission of symptoms of intracra-
nial hypertension, cognitive and locomotor functions 
improvement, and sphincter control improvement. 
A partial remission of these symptoms was assessed 
as a slight clinical improvement. In this group of pa-
tients cases with a  stable clinical course were also 
included. The criteria for radiological improvement 
were reduction in the width of the cerebral ventricles 
described by the Evans ratio and remission of active 
hydrocephalus features – the presence or widening 
of cerebral sulci and remission of periventricular lu-
cency of CSF. Long-term outpatient observation last-
ed from 1 to 3 years (average 27 months).
Results
In 74 (77.1%) patients in the early period after 
ETV a  clinical improvement was achieved, while in 
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52 (54.2%) cases it was associated with partial re-
mission of radiological signs of hydrocephalus and 
a  small reduction in the width of the cerebral ven-
tricles (Tables III and IV). Symptoms of intracranial 
hypertension presented before subsided. Significant 
improvement of cognitive functions was observed. 
In the case of patients with primary aqueductal ste-
nosis and patients with hydrocephalus of undeter-
mined etiology, locomotor functions and sphincter 
control also improved. Ventriculostomy does not 
influence the other neurological symptoms related 
to oncological disease causing hydrocephalus. In 22 
(22.9%) patients the ETV procedure resulted in slight 
improvement or remained insignificant for their 
neurological condition. These were cases without 
hypertension in the ventricular system. In such situ-
A B
C D
E
Figure 1. Endoscopic view. A  – Stages of the 
third ventriculostomy: lateral ventricle and in-
terventricular foramen in the middle. B – Stages 
of the third ventriculostomy: third ventricle floor 
with infundibulo-mammillary triangle. C – Stag-
es of the third ventriculostomy: third ventricle 
floor perforation with Fogarty catheter. D – Stag-
es of the third ventriculostomy: enlargement of 
the perforation by balloon inflation. E – Stages 
of the third ventriculostomy: third ventricle floor 
with ventriculostomy performed
Krzysztof Stachura, Ewelina Grzywna, Borys M. Kwinta, Marek M. Moskała
Videosurgery and Other Miniinvasive Techniques 4, December/2014590
ations no action against hydrocephalus beyond fur-
ther observation and causal treatment was taken. In 
1 patient with primary aqueductal stenosis, bleeding 
from the choroid plexus during the ETV procedure 
occurred. This made it difficult to continue ventric-
ulostomy safely, and surgery was abandoned. After 
2 weeks the ETV procedure was redone successfully. 
One patient presented memory disorders resulting 
from probable fornix injury for a few days after sur-
gery. In 2 cases CSF leakage from the postoperative 
wound occurred, and it was secured with additional 
skin sutures. One patient with a tumor of the cerebel-
lum, in whom surgery was complicated by persistent 
bleeding from the place where the ventriculostomy 
was made, despite external ventricular drainage 
placement, died on the fifth postoperative day.
In the assessment of the long-term effectiveness 
of ETV, oncological patients with obstructive hydro-
cephalus were excluded, since the final outcome in 
this group is conditioned by the undertaken causal 
treatment. Among 24 patients with primary aque-
ductal stenosis, during follow-up, in 2 of the cases 
the clinical condition improved and in another 2 
the width of the cerebral ventricles decreased. After 
6–12 months following surgery, in 20 (83.3%) pa-
tients in this subgroup the clinical improvement was 
Table III. Effectiveness of endoscopic third ventriculostomy in obstructive hydrocephalus of different etiol-
ogy. Early assessment – clinical presentation
Cause of hydrocephalus Clinical improvement Slight clinical 
improvement/no clinical 
improvement
Primary aqueductal stenosis 18 6
Tumor of posterior portion of the third ventricle 16 3
Cerebellopontine angle tumor 13 4
Cerebellar tumor 10 2
Multiple metastases 5 3
Mesencephalic tumor 4 1
Basilar tip aneurysm 2 –
Undefined 6 3
Total 74 (77.1%) 22 (22.9%)
Table IV. Effectiveness of endoscopic third ventriculostomy in obstructive hydrocephalus of different etiol-
ogy. Early assessment – radiological presentation 
Cause of hydrocephalus Reduction of ventricle 
diameters
Ventricle diameters 
unchanged
Primary aqueductal stenosis 12 12
Tumor of posterior portion of the third ventricle 10 9
Cerebellopontine angle tumor 9 8
Cerebellar tumor 6 6
Multiple metastases 5 3
Mesencephalic tumor 3 2
Basilar tip aneurysm 2 –
Undefined 5 4
Total 52 (54.2%) 44 (45.8%)
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maintained, of whom in 14 (58.3%) it was correlated 
with improvement of the radiological image. The re-
maining 2 patients required shunt placement. After 
12–24 months following surgery in 2 cases symptoms 
of hydrocephalus recurred, in 1 case after cranioce-
rebral injury and in another after viral infection of 
severe course. In both cases a  ventriculoperitoneal 
shunt was placed finally. Among 9 patients with hy-
drocephalus of undetermined cause, 3 required shunt 
treatment within 6 months after the ETV procedure, 
including 1 patient with a shunt placed previously to 
ETV. Treatment in patients with obstructive hydro-
cephalus caused by basilar tip aneurysm succeeded, 
with a satisfactory long-term outcome.
The assessment of effectiveness of ventriculos-
tomy in other patients is only indirect due to con-
ditions mentioned above. In 3 patients with tumor 
of the posterior portion of the third ventricle who 
(after the ETV procedure) underwent radiotherapy, 
a  ventriculoperitoneal shunt was placed because 
of recurrence of hydrocephalus features. Among 
17 patients with cerebellopontine angle tumor, in 
4 of them, directly after tumor resection, ventricu-
lostomy failed to be sufficient and in the presence 
of emerging symptoms of hydrocephalus external 
ventricular drainage and then a shunt were placed. 
In cases of cerebellar tumor, after tumor resection no 
recurrence of the symptoms of hydrocephalus were 
observed. Patients with hydrocephalus caused by 
multiple metastases never showed up in our outpa-
tient unit for long-term observation, and our efforts 
to obtain information about their outcome failed. 
Among 5 patients with a  mesencephalic tumor, 
2 died within 12 months after surgery, and the out-
come of the other 3 has remained unknown.
Discussion
Endoscopic third ventriculostomy is the most 
commonly performed neuroendoscopic procedure 
nowadays. It enables one to restore conditions of 
CSF circulation close to physiological and to avoid 
complications associated with shunt treatment in 
many patients. Although the ETV procedure has 
been performed routinely for many years in many 
centers, still of interest remain issues related to: the 
appropriate selection of cases, the surgical tech-
nique and the assessment of the effectiveness of 
the treatment.
In our series, patients scheduled for ETV surgery 
suffered from three-ventricle hydrocephalus in most 
cases resulting from primary aqueductal stenosis 
or related to oncological disease. At the same time, 
clinical and radiological presentation likely allowed 
us to exclude impaired patency of the subarachnoid 
space and/or impaired CSF resorption. Such criteria 
were adopted in order to standardize the collected 
data following the other studies [5–14]. While the 
ETV treatment in patients with primary aqueductal 
stenosis does not raise a  discussion, the cases in 
which the circulation of cerebrospinal fluid is sec-
ondarily blocked by a tumor may raise doubts [12]. 
The generally accepted rule of conduct in this sit-
uation is histopathological evaluation of the lesion 
in order to select the method of treatment or to re-
move the lesion. In 13 patients with tumor of the 
posterior portion of the third ventricle after ventric-
ulostomy, endoscopic biopsy was performed to ver-
ify the lesion. In other cases, because of increased 
vascularization of the tumor and potential bleeding, 
biopsy was abandoned. In patients with cerebello-
pontine angle tumor and cerebellar tumor, excluding 
5 cases, ventriculostomy was the temporary alter-
native for extraventricular drainage used previously. 
These were patients with large tumors, with emerg-
ing symptoms of intracranial hypertension resulting 
from hydrocephalus, and with multiple comorbidi-
ties requiring a long preparation for elective surgery. 
Yet another was the role of ventriculostomy as pal-
liative treatment. Endoscopic third ventriculostomy 
has enabled us to avoid shunt treatment in patients 
in whom causal treatment was discontinued due to: 
location and clinical staging of neoplasm, high risk 
associated with the target surgery, or the ultimate 
lack of patient agreement on the target surgery. 
The selection for ventriculostomy in patients with 
three-ventricle hydrocephalus of undetermined eti-
ology was based on empirical considerations. In pa-
tients treated previously with shunt placement, this 
method of treatment (ETV) is not always accepted, 
in line with the conviction “shunting once means 
always shunting’’ [15–18]. However, the lack of ex-
perience led us to undertake the surgery in these 
patients as well.
In addition to the clinical criteria, radiological 
evaluation of conditions to carry out the procedure 
plays a very important role in selection of patients 
for ETV. Use of head CT and/or MRI scans made with 
appropriate planes is sufficient for this purpose. The 
smallest width of the third ventricle allowing safe 
maneuvers of the endoscope is estimated to be 
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0.8–1.0 cm [9]. Hayashi et al. based on MRI scans in 
the sagittal plane determined the average distance 
between the infundibular recess and basilar tip. In 
patients with hydrocephalus it is 12 ±3.7 mm, while 
in the elderly due to displacement of the basilar ar-
tery to the front in relation to the mammillary bodies 
it may be reduced up to 6 mm [18]. Morota et al. 
made a certain observation. In hydrocephalus with 
increased intracranial pressure, in case of empty sel-
la, MRI usually reveals herniation of the anterior part 
of the third ventricle floor to the sella that changes 
the anatomical relations [19].
Endoscopic third ventriculostomy is considered 
a technically uncomplicated procedure. Using a rigid 
neuroendoscope guarantees holding the chosen tra-
jectory of access to the floor of the third ventricle. Al-
though most ventriculostomies are performed using 
a rigid neuroendoscope, there are also supporters of 
the use of a flexible version [9]. It has a smaller di-
ameter and allows the penetration of recesses of the 
ventricular system. Direct vision inspection provides 
proper anatomical and space orientation in the op-
erative field, and it minimizes the risk of injury to 
important vascular and nervous structures. However, 
the procedure can also be performed stereotaxically 
under fluoroscopic, CT or MRI control [20–22]. Sup-
porting ETV with various frameworks and frameless 
neuronavigation systems has also been reported 
[11, 23]. The crucial step in the ETV procedure is the 
perforation of the floor of the third ventricle lead-
ing to the interpeduncular cistern. The perforation in 
patients with a thin, bluish, translucent floor allow-
ing the identification of the basilar artery position 
should not cause major problems. Difficulties may 
occur if the floor of the third ventricle is thick, not 
transparent, rigid, with illegible anatomical struc-
tures. Sometimes, in such cases, discontinuation of 
the ETV procedure and subsequent shunt placement 
is advised [24–27]. In the presented series we did 
not have any situation as described above. A  trick 
that allows for verification of the basilar artery posi-
tion and choice of a safe perforation place is use of 
a Doppler microprobe [28]. The best way to perform 
ventriculostomy is using a Fogarty catheter, but it is 
not always possible. Sharp instruments and coagu-
lation must be used with extreme caution. Enlarge-
ment of the fenestration using a  balloon catheter 
should be performed at the level of the floor of the 
third ventricle, not otherwise. Effective perforation 
must include all of the layers forming the floor of the 
third ventricle – the ependymal layer of the ventri-
cle, pia mater and arachnoid mater of the interpe-
duncular cistern. It is assumed that the width of the 
fenestration cannot be less than 3–5 mm [27, 29]. 
Wood has presented ventriculostomy performed us-
ing a  laser beam [30]. Other techniques have also 
been described, but generally they do not affect the 
final result of treatment [9, 31].
The obtained effectiveness of ETV in adults is 
difficult to compare to similar studies, since they 
are mostly related to mixed age groups of patients. 
Teo, based on a review of different series of patients 
treated with ETV, assumes effectiveness of the treat-
ment in 50% to 90% in selected cases of aqueductal 
stenosis in adults. According to him, patients with 
primary or secondary aqueductal stenosis, with 
three-ventricle hydrocephalus, with an oval-shape 
third ventricle, over 2 years of age, previously shunt-
ed, who have never been a subject to radiotherapy, 
with a  thin translucent floor of the third ventricle 
have a  good prognosis. Patients who do not meet 
these criteria become shunt-dependent in 50% of 
cases [27]. Gangemi et al. evaluated the effective-
ness of ventriculostomy in treatment of obstructive 
hydrocephalus twice, based on multicenter studies 
in Italy [9, 10]. In this study involving 140 patients of 
mixed age, under observation for 6–12 years, a good 
outcome was reported in 87.1% of cases regardless 
of patients’ age and etiology of hydrocephalus.
It is believed that the clinical response of adult 
patients to ventriculostomy differs from the pedi-
atric population, because of the duration of hydro-
cephalus, the differences in CSF circulatory dynamics 
and reduced elasticity of the brain [7]. In 74 (77.1%) 
patients of our series in the early period after ETV 
a  clinical improvement was achieved, while in 52 
(54.2%) cases it was associated with partial remis-
sion of radiological symptoms of hydrocephalus. The 
first major series of adult patients treated with ETV 
was presented by Dusick et al. It included 108 pa-
tients, of whom 52 were diagnosed from idiopathic 
aqueductal stenosis, 47 from brain tumor resulting 
in non-communicative hydrocephalus, and 9 from 
other pathologies causing the obstruction in CSF 
flow. After a mean follow-up of 8 months, shunt in-
dependence in 79% of patients was reported, and 
there were 2 deaths [7]. In the more recent study of 
Woodworth et al., 124 patients were analyzed. Sev-
enty-four percent of them achieved shunt indepen-
dence, and an improvement of clinical condition was 
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observed an average of 1 month after surgery, while 
a radiological improvement was reported in 57% of 
cases and occurred at a median of 2 months after 
surgery [32]. The data describing the effectiveness 
of ventriculostomy in adults in other studies only 
slightly differ from those listed above, which mostly 
results from the adopted end points [6, 11, 33]. In 
the only existing Polish study, involving 20 patients 
over the age of 18 years, observed for an average 
of 12 months, clinical improvement was reported in 
90% of cases, and radiological improvement in 88%. 
The success rate was dependent on the etiology 
of hydrocephalus [12]. Our own observations have 
shown over 83% long-term effectiveness of ETV in 
patients with hydrocephalus due to aqueductal ste-
nosis, in 58.3% of cases confirmed radiographically. 
It was also found that the clear effect of the treat-
ment is not noticeable until a few weeks to several 
months after surgery. This is explained by the need 
to adapt the subarachnoid space to the new con-
ditions of CSF circulation [27]. The effectiveness of 
ventriculostomy in the primary aqueductal stenosis, 
if disease was diagnosed in adulthood, is assessed 
as 66–85% [5, 11, 12, 34]. Tisell et al. reported only 
50% long-term effectiveness of this treatment. The 
condition of one-third of patients, after clinical im-
provement lasting 1–12 months, deteriorated for 
unclear reasons, in spite of patent ventriculostomy. 
The worst prognosis applied to patients over 60 
years of age [14]. The results of ETV in treatment 
of three-ventricle hydrocephalus of undetermined 
etiology are always difficult to predict, but even in 
such cases, treatment should be undertaken [35]. 
Grunert et al. achieved a  50% success rate in the 
group of patients defined as above [11]. In the case 
of previously shunted patients, in mixed age groups, 
the effectiveness of ventriculostomy is in the range 
57–82% [5, 15]. Woodworth et al. postulate less im-
portance of the ETV procedure as an independent 
method of treatment, while they see ETV as a good 
complement to shunt treatment in cases of compli-
cations and necessary revision [17]. It is difficult to 
discuss the long-term effectiveness of ventriculosto-
my in patients with hydrocephalus of an oncological 
cause in the same way as before, since ventriculos-
tomy in these cases was a solution to conduct fur-
ther planned stages of treatment or was a palliative 
procedure. In 7 cases ETV did not meet our expecta-
tions, which resulted in shunt placement. The effec-
tiveness of ventriculostomy in patients with lesions 
that cause blockage of the CSF circulation pathways 
from outside, with a wide diversity of cases, ranges 
in the literature between 58% and 92% [5, 6, 11, 12, 
36]. It seems that it is also recommendable treat-
ment in patients with advanced oncological disease 
who do not have any metastases to the meninges 
and did not undergo prior radiotherapy of the brain. 
Nguyen et al., in a series of 7 patients with diagnosed 
metastases in the posterior fossa of the cranium and 
in the thalamus, in 5 cases reported improvement of 
outcome expressed as a life extension from a few to 
several weeks [37].
Postoperative radiographic evaluation of the 
ventricular system may not always give the expect-
ed image of effectiveness of ETV. This is confirmed 
by the obtained results. Buxton et al. and Melot et 
al. demonstrated that the radiological presentation 
itself might be confusing and should not be the 
only reference to the effectiveness of ETV treatment 
[38, 39]. Moreover, as Schwartz et al. observed, for 
reliable assessment of the effectiveness of ventric-
ulostomy, measurement of the width of the third 
ventricle than lateral ventricles is more important. In 
patients over 70 years of age, shunted previously or 
after meningitis, reduction of the size of the ventric-
ular system should not be expected [40, 41]. More 
reliable information on the patency of the ventric-
ulostomy may be provided by phase-contrast cine 
MRI or isotope cisternography [42, 43].
In the studied group of patients, 4 developed 
transient complications, not affecting the final out-
come, and 1 death occurred. Among the most com-
monly reported complications of ETV, the following 
have been mentioned: intraoperative arterial or 
venous bleeding, subdural hematoma, subdural hy-
groma, qualitative and quantitative disturbances 
of consciousness, oculomotor or abducent nerve 
palsy, hemiparesis, diabetes insipidus, loss of appe-
tite, menstrual cycle disorders, CSF leakage from the 
wound, and infections. Overall, the number of com-
plications does not exceed 5–15%; these are tran-
sient disorders described in 6–8%, and stable ob-
served in 0–2% of cases. The perioperative mortality 
rate is 0–1.5% [19, 25, 26, 42, 44–51]. It supports the 
recognition of ventriculostomy as a safe procedure. 
Conclusions
The best results of ETV treatment were demon-
strated for patients with hydrocephalus caused by 
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primary aqueductal stenosis. Clinical improvement 
did not correspond with reduction of cerebral ven-
tricle diameters; therefore ventricle size cannot be 
an independent criterion in the assessment of the 
effectiveness of ETV treatment. Endoscopic third 
ventriculostomy procedure is effective in patients 
treated previously with shunt placement, although 
the prediction of outcome should be cautious for 
this group. Endoscopic third ventriculostomy enables 
one to prepare patients with hydrocephalus for the 
causal treatment. It is used also as a method of pal-
liative treatment.
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